Published in Acta Physiol (Oxf) on February 08, 2010
Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci (2011) 1.55
Rare mutations in the human Na-K-Cl cotransporter (NKCC2) associated with lower blood pressure exhibit impaired processing and transport function. Am J Physiol Renal Physiol (2011) 1.06
Physiology and pathophysiology of SLC12A1/2 transporters. Pflugers Arch (2013) 0.96
Differential regulation of NFAT5 by NKCC2 isoforms in medullary thick ascending limb (mTAL) cells. Am J Physiol Renal Physiol (2011) 0.87
Plasma Membrane Targeting of Endogenous NKCC2 in COS7 Cells Bypasses Functional Golgi Cisternae and Complex N-Glycosylation. Front Cell Dev Biol (2017) 0.76
Tubular transport: core curriculum 2010. Am J Kidney Dis (2010) 0.76
Functional consequences of NKCC2 splice isoforms: insights from a Xenopus oocyte model. Am J Physiol Renal Physiol (2014) 0.75
Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter. Br J Pharmacol (2015) 0.75
Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol (1997) 15.19
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65
Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis (1987) 9.25
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity (1996) 8.27
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol (2000) 5.20
CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol (1994) 4.62
Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest (1997) 2.76
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst (1998) 2.75
Seismicity remotely triggered by the magnitude 7.3 landers, california, earthquake. Science (1993) 2.61
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother (2007) 2.49
Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA (1994) 2.40
Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association. CMAJ (1995) 2.23
Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med (1999) 2.10
Basic statistics for clinicians: 1. Hypothesis testing. CMAJ (1995) 2.07
Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg (2000) 1.98
Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res (2001) 1.96
Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol (1990) 1.96
Size matters more than chemistry for cloud-nucleating ability of aerosol particles. Science (2006) 1.96
Role of K(V)LQT1 in cyclic adenosine monophosphate-mediated Cl(-) secretion in human airway epithelia. Am J Respir Cell Mol Biol (2000) 1.85
Identification of Erwinia amylovora, the Fireblight Pathogen, by Colony Hybridization with DNA from Plasmid pEA29. Appl Environ Microbiol (1988) 1.80
The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J (2003) 1.75
T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74
Neurodevelopmental therapy and upper-extremity inhibitive casting for children with cerebral palsy. Dev Med Child Neurol (1991) 1.73
Reliability of the Canadian emergency department triage and acuity scale: interrater agreement. Ann Emerg Med (1999) 1.72
Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med (2001) 1.70
Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke (2010) 1.69
Prevention of urethral stricture recurrence using clean intermittent self-catheterization. Br J Urol (1994) 1.64
Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ (1989) 1.60
Revascularization in acute ischaemic stroke using the penumbra system: the first single center experience. Eur J Neurol (2009) 1.59
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb (1991) 1.57
Comparison of stent free cell area and cerebral lesions after unprotected carotid artery stent placement. Eur J Vasc Endovasc Surg (2011) 1.51
Problems with percentiles. Int J Epidemiol (1986) 1.49
Evaluation of the protected brush catheter and bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. J Intensive Care Med (1993) 1.49
Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology (2012) 1.49
Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity. J Biol Chem (1997) 1.49
Cholinergic ion secretion in human colon requires coactivation by cAMP. Am J Physiol (1998) 1.48
Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis (2004) 1.46
Evaluation of the sacroanal motor pathway by magnetic and electric stimulation in patients with fecal incontinence. Dis Colon Rectum (2001) 1.45
Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler (1986) 1.45
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol (2000) 1.43
The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways. J Clin Invest (1998) 1.42
Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. Complement Inflamm (1991) 1.41
Electrophoretic karyotype for Dictyostelium discoideum. Proc Natl Acad Sci U S A (1990) 1.40
Purinergic inhibition of the epithelial Na+ transport via hydrolysis of PIP2. FASEB J (2004) 1.40
The nurse's role in a team conference. Nurs Manage (1990) 1.40
Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons. Genes Immun (2005) 1.38
Outcome measures for research in adult women with symptoms of lower urinary tract dysfunction. Standardization Committee of the International Continence Society. Acta Obstet Gynecol Scand (2001) 1.38
Basic statistics for clinicians: 2. Interpreting study results: confidence intervals. CMAJ (1995) 1.38
Molecular and functional characterization of the small Ca(2+)-regulated K+ channel (rSK4) of colonic crypts. Pflugers Arch (1999) 1.38
The gene encoding the cellulase (Avicelase) Cel1 from Streptomyces reticuli and analysis of protein domains. Mol Microbiol (1992) 1.35
Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem (2000) 1.35
Characteristics of an exochitinase from Streptomyces olivaceoviridis, its corresponding gene, putative protein domains and relationship to other chitinases. Eur J Biochem (1993) 1.35
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Innate immune receptor expression in normal brain aging. Neuroscience (2007) 1.34
Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol (1992) 1.33
Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int (2002) 1.33
Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. J Biol Chem (2001) 1.31
KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene (2006) 1.29
Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol (2004) 1.29
The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood (1996) 1.29
Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol (2003) 1.28
Cl- transport by cystic fibrosis transmembrane conductance regulator (CFTR) contributes to the inhibition of epithelial Na+ channels (ENaCs) in Xenopus oocytes co-expressing CFTR and ENaC. J Physiol (1998) 1.28
14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem (2000) 1.27
Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett (1997) 1.24
Wild type but not deltaF508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes. FEBS Lett (1996) 1.24
Seasonal variation in depressive disorders and suicidal deaths in New South Wales. Br J Psychiatry (1982) 1.24
Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum (1986) 1.22
The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry (2000) 1.22
Improving memory: a role for phosphodiesterases. Curr Pharm Des (2006) 1.22
The cystic fibrosis transmembrane conductance regulator (CFTR) inhibits ENaC through an increase in the intracellular Cl- concentration. EMBO Rep (2001) 1.21
Effect of time elapsed since previous voiding on the detection of Chlamydia trachomatis antigens in urine. Eur J Clin Microbiol Infect Dis (1993) 1.19
Transfer and expression of foreign genes in mammalian cells. Biotechniques (2000) 1.18
The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel. Proc Natl Acad Sci U S A (1999) 1.17
Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p. Biochemistry (2001) 1.17
Inhibition of amiloride-sensitive epithelial Na(+) absorption by extracellular nucleotides in human normal and cystic fibrosis airways. Am J Respir Cell Mol Biol (2000) 1.17
The role of the IsK protein in the specific pharmacological properties of the IKs channel complex. Br J Pharmacol (1997) 1.16
Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol (1993) 1.15
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice. Oncogene (2009) 1.15
Functional properties of the type-3 InsP3 receptor in 16HBE14o- bronchial mucosal cells. J Biol Chem (1998) 1.14
Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt (1997) 1.14
Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev (2000) 1.13
Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings. Scand J Urol Nephrol (1979) 1.13
A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child. Am J Hum Genet (1998) 1.12
Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators. Mol Cell Biol (1996) 1.12
Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family. FEBS Lett (2000) 1.12
Defective cholinergic Cl(-) secretion and detection of K(+) secretion in rectal biopsies from cystic fibrosis patients. Am J Physiol Gastrointest Liver Physiol (2000) 1.11
Control of epithelial Na+ conductance by the cystic fibrosis transmembrane conductance regulator. Pflugers Arch (2000) 1.11
Basopenia following cigarette smoking. Indian J Med Res (1980) 1.11
Analysis of transcription of the Staphylococcus aureus aerobic class Ib and anaerobic class III ribonucleotide reductase genes in response to oxygen. J Bacteriol (2001) 1.11
Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus (2004) 1.11
Changes in growth control and growth requirements associated with neoplastic transformation in vitro. J Natl Cancer Inst (1974) 1.10
Modelling psychosocial effects of exposure to solid waste facilities. Soc Sci Med (1993) 1.10
Rescue of the mineralocorticoid receptor knock-out mouse. Pflugers Arch (1999) 1.10